|
|
|
|
|
|
Sponsors and Collaborators: |
Memorial Sloan-Kettering Cancer Center University of New Mexico |
Information provided by: | Memorial Sloan-Kettering Cancer Center |
ClinicalTrials.gov Identifier: | NCT00611598 |
The purpose of this study is to help us better understand the cellular changes that may lead to the development of lung cancer. We want to compare people with a second primary lung cancer with those who have only a first primary lung cancer. We hope to use the information obtained in this study as the basis for future studies and will not regard the results from this study as final.
We will analyze your blood cells and DNA to measure the changes in several genes that we believe may be involved in lung cancer. We also want to evaluate the capacity for your DNA to repair itself.
Condition | Intervention |
Lung Cancer Single Primary Lung Cancer Second Primary Lung Cancer |
Other: Blood draw and Questionnaires |
MedlinePlus related topics: | Cancer Lung Cancer |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | DNA Repair and Genetic Susceptibility to Lung Cancer |
Enrollment: | 218 |
Study Start Date: | February 2003 |
Estimated Study Completion Date: | September 2009 |
Estimated Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
1
second primary lung cancer
|
Other: Blood draw and Questionnaires
Pt will have three green top tubes of blood drawn. The questionnaire will be filled out by the study subject. This may be completed at home and mailed in a provided stamped addressed envelope if the patient prefer, or obtained by phone interview with a research assistant.
|
2
single primary lung cancer
|
Other: Blood draw and Questionnaires
Pt will have three green top tubes of blood drawn. The questionnaire will be filled out by the study subject. This may be completed at home and mailed in a provided stamped addressed envelope if the patient prefer, or obtained by phone interview with a research assistant.
|
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
MSKCC Clinic
Inclusion Criteria:
Controls will be eligible for inclusion if
Exclusion Criteria:
United States, New York | |||||
Memorial Sloan Kettering Cancer Center | |||||
New York, New York, United States, 10065 |
Memorial Sloan-Kettering Cancer Center |
University of New Mexico |
Principal Investigator: | Irene Orlow, PhD | Memorial Sloan-Kettering Cancer Center |
Memorial Sloan-Kettering Cancer Center 
  |
Responsible Party: | Memorial Sloan-Kettering Cancer Center ( Irene Orlow, PhD ) |
Study ID Numbers: | 03-003 |
First Received: | January 28, 2008 |
Last Updated: | July 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00611598 |
Health Authority: | United States: Institutional Review Board |
|
|
|